Skip to Main Content

Author Details

Andrew Berchuck
Duke School of Medicine
1983
518
88
PMIDPaper TitleJournal TitlePublished Year
35962742Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board.Oncologist2023
37961178Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms.bioRxiv2023
37956617High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.Gynecol Oncol2023
38049490Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness.Sci Rep2023
38033361Efficacy of cyclin-dependent kinase 4/6 inhibitors in combination with hormonal therapy in patients with recurrent granulosa cell tumor of the ovary: A case series.Gynecol Oncol Rep2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37369443Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.Can J Surg2023
37436712A framework for assessing interactions for risk stratification models: the example of ovarian cancer.J Natl Cancer Inst2023
36723938Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.JAMA Netw Open2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36826816Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.JAMA Netw Open2023
36794910Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD study.JNCI Cancer Spectr2023
36306380Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis.Cancer Epidemiol Biomarkers Prev2023
34776242Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol2022
35477150Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
35767962G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironment.Cell Rep2022
35702670Pleiotropic <i>MLLT10</i> variation confers risk of meningioma and estrogen-mediated cancers.Neurooncol Adv2022
35454861CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.Cancers (Basel)2022
35654828Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers.Commun Biol2022
36551751Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian Cancer.Cancers (Basel)2022
36182623Effects of risk factors for ovarian cancer in women with and without endometriosis.Fertil Steril2022
36075393NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.J Natl Compr Canc Netw2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
35905726Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer.Cell Rep2022
35867953Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia.J Clin Oncol2022
36058401Race, Affordability and Utilization of Supportive Care in Ovarian Cancer Patients.J Pain Symptom Manage2022
36351338Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.J Natl Compr Canc Netw2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35064059Reproductive Factors Do Not Influence Survival with Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
33828978Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance.Front Oncol2021
33720082Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" Tumors.Int J Gynecol Pathol2021
33545690Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021
33619020Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.Cancer Epidemiol Biomarkers Prev2021
34607872Ovarian Cancer Epidemiology, Healthcare Access and Disparities (ORCHiD): methodology for a population-based study of black, Hispanic and white patients with ovarian cancer.BMJ Open2021
34090707Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada.Gynecol Oncol2021
34200374Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia.Cancers (Basel)2021
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
33400095Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.Target Oncol2021
33037137Targeting Dormant Ovarian Cancer Cells <i>In Vitro</i> and in an <i>In Vivo</i> Mouse Model of Platinum Resistance.Mol Cancer Ther2021
32976626Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.Int J Cancer2021
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
31469419Identification of novel epithelial ovarian cancer loci in women of African ancestry.Int J Cancer2020
31937450Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.Gynecol Oncol2020
32028322Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored.Epidemiology2020
33391655Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atrium.J Surg Case Rep2020
  • 1 - 50 of 518

Recommended Authors

Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 15
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 2
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 23
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 37
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 5
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 11
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 3
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 21
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 3
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 5
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 3
Denise C Connolly
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 10
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 22
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 10
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 8
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 10
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 4
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 5
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 9
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 7
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 8
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 17
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 10
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 164
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 116
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 109
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 108
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 107
Anna H Wu
University of Southern California
Co-authored papers 106
Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
Co-authored papers 101
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 98
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 98
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 93
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 84
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 83
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 83
Hoda Anton-Culver
University of California irvine
Co-authored papers 82
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 81
Aleksandra Gentry-Maharaj
UCL EGA Institute for Women's Health, University College London
Co-authored papers 76
Honglin Song
University of Cambridge
Co-authored papers 73
Elisa V Bandera
Co-authored papers 71
Alice S Whittemore
Co-authored papers 70
Nicolas Wentzensen
National Cancer Institute, National Institutes of Health
Co-authored papers 68
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 67
Weiva Sieh
Co-authored papers 64
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 63
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 62
Jonathan Tyrer
Co-authored papers 57
Pamela J Thompson
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 56
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 55
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 53
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 51
Diether Lambrechts
Co-authored papers 51
Release 1.2